PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,279,384 | -11.9% | 2,437,742 | +21.7% | 0.00% | 0.0% |
| Q2 2023 | $28,677,691 | +146.0% | 2,002,632 | +22.6% | 0.00% | – |
| Q1 2023 | $11,658,979 | -38.7% | 1,632,910 | -3.6% | 0.00% | -100.0% |
| Q4 2022 | $19,011,516 | +11.2% | 1,694,431 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $17,098,000 | +28.4% | 1,543,150 | -2.2% | 0.00% | – |
| Q2 2022 | $13,318,000 | -29.0% | 1,577,737 | +14.5% | 0.00% | -100.0% |
| Q1 2022 | $18,761,000 | -35.2% | 1,378,517 | -6.4% | 0.00% | 0.0% |
| Q4 2021 | $28,974,000 | -23.7% | 1,473,125 | +24.5% | 0.00% | 0.0% |
| Q3 2021 | $37,970,000 | -3.3% | 1,182,878 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $39,282,000 | +28.2% | 1,160,437 | +42.2% | 0.00% | 0.0% |
| Q1 2021 | $30,647,000 | +16.6% | 815,940 | +3.2% | 0.00% | 0.0% |
| Q4 2020 | $26,273,000 | -0.1% | 790,880 | +10.3% | 0.00% | 0.0% |
| Q3 2020 | $26,289,000 | +10.0% | 716,912 | -1.2% | 0.00% | 0.0% |
| Q2 2020 | $23,890,000 | +58.2% | 725,927 | +24.1% | 0.00% | 0.0% |
| Q1 2020 | $15,104,000 | -24.3% | 584,946 | -8.7% | 0.00% | 0.0% |
| Q4 2019 | $19,952,000 | – | 640,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |